HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.

Abstract
Mutations in the four-and-a-half LIM domain 1 (FHL1) gene, which encodes a 280-amino-acid protein containing four LIM domains and a single zinc-finger domain in the N-terminal region, have been associated with a broad clinical spectrum of X-linked muscle diseases encompassing a variety of different phenotypes. Patients might present with a scapuloperoneal myopathy, a myopathy with postural muscle atrophy and generalized hypertrophy, an Emery-Dreifuss muscular dystrophy, or an early onset myopathy with reducing bodies. It has been proposed that the phenotypic variability is related to the position of the mutation within the FHL1 gene. Here, we report on three British families with a heterogeneous clinical presentation segregating a single FHL1 gene mutation and haplotype, suggesting that this represents a founder mutation. The underlying FHL1 gene mutation was detected by direct sequencing and the founder effect was verified by haplotype analysis of the FHL1 gene locus. A 3-bp insertion mutation (p.Phe127_Thr128insIle) within the second LIM domain of the FHL1 gene was identified in all available affected family members of the three families. Haplotype analysis of the FHL1 region on Xq26 revealed that the families shared a common haplotype. The p.Phe127_Thr128insIle mutation in the FHL1 gene therefore appears to be a British founder mutation and FHL1 gene screening, in particular of exon 6, should therefore be indicated in British patients with a broad phenotypic spectrum of X-linked muscle diseases.
AuthorsAnna Sarkozy, Christian Windpassinger, Judith Hudson, Charlotte F Dougan, Bryan Lecky, David Hilton-Jones, Michelle Eagle, Richard Charlton, Rita Barresi, Hanns Lochmüller, Kate Bushby, Volker Straub
JournalEuropean journal of human genetics : EJHG (Eur J Hum Genet) Vol. 19 Issue 10 Pg. 1038-44 (Oct 2011) ISSN: 1476-5438 [Electronic] England
PMID21629301 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FHL1 protein, human
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • Muscle Proteins
Topics
  • Adult
  • Biopsy
  • Exons
  • Family
  • Female
  • Founder Effect
  • Genetic Diseases, X-Linked (genetics, metabolism, pathology)
  • Haplotypes
  • Humans
  • Intracellular Signaling Peptides and Proteins (genetics)
  • LIM Domain Proteins (genetics)
  • Male
  • Middle Aged
  • Muscle Proteins (genetics)
  • Muscle, Skeletal (metabolism, pathology)
  • Muscular Diseases (genetics, metabolism, pathology, physiopathology)
  • Mutation (genetics)
  • Pedigree
  • Phenotype
  • United Kingdom

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: